Filing Details
- Accession Number:
- 0001209191-23-050492
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-25 17:04:12
- Reporting Period:
- 2023-09-25
- Accepted Time:
- 2023-09-25 17:04:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1782223 | Pyxis Oncology Inc. | PYXS | Pharmaceutical Preparations (2834) | 831160910 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1796310 | Ann Pamela Connealy | C/O Pyxis Oncology, Inc. 321 Harrison Avenue Boston MA 02118 | Cfo And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-09-25 | 12,000 | $1.67 | 804,106 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price of common stock purchased by the Reporting Person in open market transactions. The range of purchase prices on the transaction date was $1.615 to $1.70 per share. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each price.
Billionaire Hedge Funds
